References
- Sipponen P, Hyvarinen H. Role of H. pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 1993; 28: 615–25
- Marshall B J. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116–28
- Slomiany B L, Murty V LN, Piotrowski J, Slomiany A. Gastroprotective agents in mucosal defense against H. pylori. Gen Pharmacol 1994; 25: 833–4
- Pavicic MAMP J, Namavar F, Verboom T, Van Winkelhoff A J, DeGraaf J. In vitro susceptibility of H. pylori to several antimicrobial combinations. Antimicrob Agents Chemother 1993; 37: 1184–6
- McGowan C C, Cover T L, Blaser M J. The proton pump inhibitor omeprazole inhibits acid survival of H. pylori by a urease-independent mechanism. Gastroenterology 1994; 107: 738–43
- Sahm D F, Washington J A. Antibacterial susceptibility test: I dilution methods. Manual of clinical microbiology, A Balows, et al. Am Soc Microbiol, Washington, DC 1991; 1105–16
- Slomiany B L, Piotrowski J, Okazaki K, Grzelinska E, Slomiany A. Nature of the enhancement of the protective qualities of gastric mucus by sucralfate. Digestion 1989; 44: 222–31
- Hui W M, Lam S K, Ho J, Ng I, Lau W Y, Branicki F J, et al. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and C. pylori. Am J Med 1988; 86: 60–5
- Barbara L, Biasco G, Capurso L, Dobrilla G, Lalli A, Paganelli G M, et al. Effects of sucralfate and sulglycotide treatment on i active gastritis and H. pylori colonization of gastric mucosa in non-ulcer dyspepsia patients. Am J Gastroenterol 1990; 85: 1109–13
- Rauws E AJ, Tytgat G NJ. Cure of duodenal ulcer associated with eradication of H. pylori. Lancet 1990; 335: 1233–5